Journal of Hepatology
Volume 49, Issue 6 , Pages 1038-1045 , December 2008

Genetic factors of susceptibility and of severity in primary biliary cirrhosis

  • Raoul Poupon

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Saint-Antoine, Service d’Hépatologie & Centre de Référence des Maladies Inflammatoires des Voies Biliaires, 184, rue du Faubourg Saint-Antoine, F-75571 Paris Cedex 12, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 1 49 28 23 77; fax: +33 1 49 28 21 07.
    • ,
  • Chen Ping

      Affiliations

    • Centre National du Génotypage, CP 5721, 91057 Evry Cedex, France
    • ,
  • Yves Chrétien

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Saint-Antoine, Service d’Hépatologie & Centre de Référence des Maladies Inflammatoires des Voies Biliaires, 184, rue du Faubourg Saint-Antoine, F-75571 Paris Cedex 12, France
    • ,
  • Christophe Corpechot

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Saint-Antoine, Service d’Hépatologie & Centre de Référence des Maladies Inflammatoires des Voies Biliaires, 184, rue du Faubourg Saint-Antoine, F-75571 Paris Cedex 12, France
    • ,
  • Olivier Chazouillères

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Saint-Antoine, Service d’Hépatologie & Centre de Référence des Maladies Inflammatoires des Voies Biliaires, 184, rue du Faubourg Saint-Antoine, F-75571 Paris Cedex 12, France
    • ,
  • Tabassome Simon

      Affiliations

    • AP-HP, Hôpital Saint-Antoine, Unité de Recherche Clinique Est, F-75012 Paris, France
    • ,
  • Simon C. Heath

      Affiliations

    • Centre National du Génotypage, CP 5721, 91057 Evry Cedex, France
    • ,
  • Fumihiko Matsuda

      Affiliations

    • Centre National du Génotypage, CP 5721, 91057 Evry Cedex, France
    • ,
  • Renée E. Poupon

      Affiliations

    • AP-HP, Hôpital Saint-Antoine, Service d’Hépatologie & Centre de Référence des Maladies Inflammatoires des Voies Biliaires, 184, rue du Faubourg Saint-Antoine, F-75571 Paris Cedex 12, France
    • ,
  • Chantal Housset

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Tenon, Service de Biochimie et d’Hormonologie, F-75020 Paris, France
    • ,
  • Véronique Barbu

      Affiliations

    • UPMC University of Paris 06, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • INSERM, UMRS_893, CdR Saint-Antoine, F-75012 Paris, France
    • AP-HP, Hôpital Saint-Antoine, Laboratoire Commun de Biologie et Génétique Moléculaires, F-75012 Paris, France

Received 3 June 2008 ,Revised 4 July 2008 ,Accepted 17 July 2008.

References 

  1. Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME. Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis. 2005;25:265–280
  2. Jones DE, Donaldson PT. Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis. 2003;7:841–864
  3. Selmi C, Invernizzi P, Zuin M, Podda M, Seldin MF, Gershwin ME. Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun. 2005;6:543–556
  4. Juran BD, Lazaridis KN. Genomics and complex liver disease: challenges and opportunities. Hepatology. 2006;44:1380–1390
  5. Donaldson PT, Baragiotta A, Heneghan MA, Floreani A, Venturi C, Underhill JA, et al. HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study. Hepatology. 2006;44:667–674
  6. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol. 2000;32:538–541
  7. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506–511
  8. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Mol Endocrinol. 2003;31:21–36
  9. Krishnan S, Chowdhury B, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol. 2006;18:230–243
  10. Schott E, Witt H, Pascu M, van Boemmel F, Weich V, Bergk A, et al. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease. Eur J Gastroenterol Hepatol. 2007;19:947–951
  11. Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology. 2008;47:563–570
  12. Poupon R, Poupon RE. Treatment of primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:615–628
  13. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353:1261–1273
  14. Takahashi M, Matsuda F, Margetic N, Lathrop M. Automated identification of single nucleotide polymorphisms from sequencing data. J Bioinform Comput Biol. 2003;1:253–265
  15. Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, et al. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics. 2001;17:654–655
  16. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered. 2000;50:133–139
  17. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 2001;19:225–252
  18. Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 1996;5:1075–1080
  19. Oaks MK, Hallett KM, Penwell RT, Stauber EC, Warren SJ, Tector AJ. A native soluble form of CTLA-4. Cell Immunol. 2000;201:144–153
  20. Fan LY, Tu XQ, Cheng QB, Zhu Y, Feltens R, Pfeiffer T, et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol. 2004;10:3056–3059
  21. Bittencourt PL, Palacios SA, Farias AQ, Abrantes-Lemos CP, Cancado EL, Carrilho FJ, et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2003;18:1061–1066
  22. Donaldson P, Veeramani S, Baragiotta A, Floreani A, Venturi C, Pearce S, et al. Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007;5:755–760
  23. Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, et al. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol. 2004;65:622–631
  24. Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005;32:219–224
  25. Mitchell SA, Grove J, Spurkland A, Boberg KM, Fleming KA, Day CP, et al. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut. 2001;49:288–294
  26. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol. 1999;31:242–247
  27. Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, et al. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis. J Hepatol. 1999;30:232–236
  28. Tanaka A, Quaranta S, Mattalia A, Coppel R, Rosina F, Manns M, et al. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis. J Hepatol. 1999;30:826–829
  29. Donaldson PT. TNF gene polymorphisms in primary biliary cirrhosis: a critical appraisal. J Hepatol. 1999;31:366–368
  30. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut. 2001;48:397–402
  31. Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol. 2005;204:216–237
  32. Sarkadi B, Homolya L, Szakacs G, Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev. 2006;86:1179–1236
  33. Lam P, Wang R, Ling V. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. Biochemistry. 2005;44:12598–12605
  34. Kimura Y, Selmi C, Leung PS, Mao TK, Schauer J, Watnik M, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology. 2005;41:55–63
  35. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. Hepatology. 2006;44:1564–1571
  36. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194–1202
  37. Karlsen TH, Lie BA, Frey Froslie K, Thorsby E, Broome U, Schrumpf E, et al. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. Gastroenterology. 2006;131:781–787
  38. Banales JM, Arenas F, Rodriguez-Ortigosa CM, Saez E, Uriarte I, Doctor RB, et al. Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger. Hepatology. 2006;43:266–275
  39. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol. 2001;69:522–530
  40. Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology. 1993;105:572–578
  41. Medina JF, Martinez A, Vazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology. 1997;25:12–17
  42. Prieto J, Garcia N, Marti-Climent JM, Penuelas I, Richter JA, Medina JF. Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology. 1999;117:167–172
  43. Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I, et al. Ae2_a,b deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology. 2008;134:1482–1493

☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the materials involved either in the past or present and they did not receive funding from the manufacturers to carry out their research.

PII: S0168-8278(08)00602-8

doi: 10.1016/j.jhep.2008.07.027

Journal of Hepatology
Volume 49, Issue 6 , Pages 1038-1045 , December 2008

Article Tools

* Image Usage & Resolution